Article ID Journal Published Year Pages File Type
8740932 Journal of Microbiology, Immunology and Infection 2018 9 Pages PDF
Abstract
Levofloxacin prophylaxis in HSCT recipients is associated with the emergence of fluoroquinolone-resistant Gram-negative bacteria. The risk factors and clinical outcomes of bacteremia differ between allo- and auto-HSCT recipients, and these differences should be taken into account when designing strategies to prevent bacteremia.
Related Topics
Life Sciences Immunology and Microbiology Immunology
Authors
, , , , , , , , , ,